Skip to main navigation Skip to search Skip to main content

A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects with Epllepsy with a Predictable Seizure Pattern

SUNY Downstate Health Sciences University

Project: Research

Project Details

StatusFinished
Effective start/end date09/18/18 → 09/17/20

Funding

  • Engage Therapeutics Incorporated: $89,907.65